FDA Asks Small Dispensers to Report Drug Tracking Info
Published Date: 11/21/2025
Notice
Summary
The FDA is asking small medicine dispensers to share info about how they track prescription drugs to keep the supply chain safe and secure. This new info collection is part of a law that helps trace medicines electronically, making sure they’re real and safe. Comments on this plan are open until December 22, 2025, and it could affect small dispensers’ paperwork and processes.
Analyzed Economic Effects
4 provisions identified: 0 benefits, 4 costs, 0 mixed.
Small dispensers asked to complete DSCSA assessment
If you run a medicine dispenser with 25 or fewer full‑time employees, FDA is asking you (or an entity representing you) to answer an assessment questionnaire about electronic package‑level drug tracing. FDA estimates 922 respondents will complete the questionnaire, that it will take about 2 hours to compile answers and respond, and that respondents will have 45 days to complete the questionnaire after the link is posted.
Required coordination with third‑party partners
FDA expects respondents to coordinate with third‑party entities (like solution providers, wholesale distributors, or consultants). For screener questions, FDA estimates 692 respondents will make 1,384 disclosures at about 0.1 hour each; for full assessment responses, FDA estimates 461 respondents will coordinate with two partners at about 2 hours per coordination.
Large email outreach to industry contacts
FDA plans to send 18,430 invitation emails to firms on its industry stakeholder list asking them to consider the assessment. The agency estimates it will take about 0.1 hour (6 minutes) to read each invitation and decide whether to participate.
Recordkeeping recommendation for one year
FDA recommends that respondents keep records generated while answering the assessment and retain questionnaire responses for at least 1 year after FDA publishes its final report. FDA estimates recordkeeping will take about 0.5 hour per responding entity.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12445 — Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Traction Device
The FDA is officially putting the endoscopic traction device into Class II, meaning it now has special safety rules but fewer hurdles than the strictest category. This change helps make sure the device is safe and effective while making it easier for patients to get access to this cool medical tool. The new rules took effect on June 22, 2026, and could speed up innovation without extra costs for makers.
2026-12444 — Medical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Light-Projecting Measuring Device
The FDA is officially putting the endoscopic light-projecting measuring device into Class II, meaning it now has special safety rules but fewer hurdles than the strictest category. This change helps make sure the device is safe and effective while speeding up patient access to cool new tech. The new rules took effect June 22, 2026, and could save time and money for makers and users alike.
2026-12367 — Epizyme, Inc.; Withdrawal of Approval of New Drug Application for TAZVERIK (Tazemetostat) Tablet, 200 Milligrams
Epizyme, Inc. has asked the FDA to withdraw approval for their cancer drug TAZVERIK (200 mg tablets), effective June 22, 2026. This means TAZVERIK will no longer be officially approved for treating certain sarcomas and lymphomas, affecting patients and healthcare providers relying on it. The change might impact treatment options and insurance coverage, so folks should check with their doctors about next steps.
2026-12443 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Samples
The FDA is officially putting a simple test that spots proteins from Bacillus bacteria in human samples into a safer, easier-to-manage category called Class II. This change helps make sure the test is safe and works well while speeding up patient access to cool new medical tools. The new rules kicked in on June 22, 2026, but have been in effect since February 3, 2023, making life simpler for device makers and patients alike.
2026-12245 — Authorization of Emergency Use for Two Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
The FDA just gave the green light for two new animal drugs to fight the nasty New World screwworm, a bug that harms cattle, horses, pigs, and even exotic animals. These emergency approvals started in April 2026 to help protect U.S. livestock and wildlife quickly. Farmers, vets, and animal lovers can now use these treatments to stop infestations and keep animals safe without delay.
2026-12237 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles and Medicated Feeds
The FDA is updating how companies that make special animal medicines and feeds keep their records and follow quality rules. This affects manufacturers of Type A medicated articles and medicated feeds, helping ensure safe and reliable products for animals. Comments on these changes are open until July 20, 2026, and the updates aim to keep things clear without adding extra costs.
Previous / Next Documents
Previous: 2025-20642 — Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Student Assistance General Provisions-Student Right To Know (SRK)
The Department of Education wants to keep collecting info about the Student Right To Know rules without changing anything. This affects schools and governments who share important student data, and they’re asking for public comments by December 22, 2025. No new costs or changes, just a smooth extension to keep things running on time.
Next: 2025-20644 — Agency Information Collection Activity: Civil Rights Discrimination Complaint
The Department of Veterans Affairs is updating its Civil Rights Discrimination Complaint form and wants your feedback by January 20, 2026. This affects veterans and others who feel their civil rights were violated by VA staff. The goal is to make the form clearer and easier to use without adding extra hassle or cost.